Retraction: Secreted Frizzled-Related Protein 4 Inhibits Glioma Stem-Like Cells by Reversing Epithelial to Mesenchymal Transition, Inducing Apoptosis and Decreasing Cancer Stem Cell Properties (PLoS ONE (2015) 10:6 (e0127517) DOI: 10.1371/journal.pone.0127517);Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Bhuvanalakshmi, G ^a   Arfuso, Frank ^b,c   Millward, Michael ^d   Dharmarajan, Arun ^b   Warrier, Sudha ^a,b  

^a Manipal Academy of Higher Education   (India)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CALCIUM ION; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; NERVE CELL ADHESION MOLECULE; SECRETED FRIZZLED RELATED PROTEIN 4; TEMOZOLOMIDE; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TUMOR MARKER; UVOMORULIN; WNT PROTEIN; ABC TRANSPORTER; ABCC4 PROTEIN, HUMAN; ABCG2 PROTEIN, HUMAN; CADHERIN; DACARBAZINE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; ONCOPROTEIN; SFRP4 PROTEIN, HUMAN; TUMOR PROTEIN; TWIST RELATED PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER INHIBITION; CANCER STEM CELL; CELL INVASION; CELL MOTION; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFICACY; EPITHELIAL MESENCHYMAL TRANSITION; GLIOMA STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO CULTURE; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR ENGRAFTMENT; ANALOGS AND DERIVATIVES; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETICS; GLIOMA; MALE; METABOLISM; SNAIL; TUMOR CELL LINE;

GASTROPODA; MUS MUSCULUS;

ANIMALS; APOPTOSIS; ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 2; ATP-BINDING CASSETTE TRANSPORTERS; CADHERINS; CELL LINE, TUMOR; DACARBAZINE; EPITHELIAL-MESENCHYMAL TRANSITION; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS; SNAILS; TWIST-RELATED PROTEIN 1;

EID: 84931275698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0268372     Document Type: Erratum

References (49)

1. Louis DN, Ohgaki H, Wiestler DO, Cavenee WK, Burger PC, Jouvet A et al. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol 2007 Aug 114(2): 97-109. PMID: 17618441
2. Apuzzo MLJ: Malignant Cerebral Glioma (Neurosurgical Topics, 2). Park Ridge, IL: American Association of Neurological Surgeons, 1990.
3. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004 Nov 18; 432(7015):396-401. PMID: 15549107
4. Liu G, Yuan X, Zeng Z, Tunici P, Hiushan NG, Abdulkadir IR, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006 Dec 2; 5:67. PMID: 17140455
5. Gong A and Huang S.FoxM1 and Wntß-catenin Signaling in Glioma Stem Cells. Cancer Res 2012 Nov 15; 72(22):5658-62. doi: 10.1158/0008-5472.CAN-12-0953 PMID: 23139209
6. Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J 2012 Jun 13; 31(12):2714-36. doi: 10.1038/emboj.2012.150 PMID: 22617422
7. Rampazzo E, Persano L, Pistollato F, Moro E, Frasson C, Porazzi P, et al.Wnt activation promotes neuronal differentiation of Glioblastoma. Cell Death Dis 2013 Feb 21; 4:e500. doi: 10.1038/cddis.2013.32 PMID: 23429286
8. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009 Jul 17(1):9-26. doi: 10.1016/j.devcel.2009.06.016 PMID: 19619488
9. Drake JM, Friis RR, Dharmarajan AM. The role of sFRP4, a secreted frizzled-related protein, in ovulation. Apoptosis 2003 Aug 8(4):389-97. PMID: 12815282
10. Guo K, Wolf V, Dharmarajan AM, Feng Z, Bielke W, Saurer S, et al. Apoptosis- associated gene expression in the corpus luteum of the rat. Biol Reprod 1998 Mar 58(3):739-46. PMID: 9510961
11. Hsieh M, Mulders SM, Friis RR, Dharmarajan A, Richards JS. Expression and localization of secreted frizzled-related protein-4 in the rodent ovary: evidence for selective up-regulation in luteinized granulosa cells. Endocrinology 2003 Oct 144(10):4597-606. PMID: 12960062
12. Lacher MD, Siegenthaler A, Jager R, Yan X, Hett S, Xuan L, et al. Role of DDC-4/sFRP-4, a secreted frizzled-related protein, at the onset of apoptosis in mammary involution. Cell Death Differ 2003 May 10(5):528-38. PMID: 12728251
13. Wolf V, Ke G, Dharmarajan AM, Bielke W, Artuso L, Saurer S, et al. DDC-4, an apoptosis-associated gene, is a secreted frizzled relative. FEBS Lett 1997 Nov 17; 417(3):385-9. PMID: 9409757
14. Constantinou T, Baumann F, Lacher MD, Saurer S, Friis R, Dharmarajan A.et al. SFRP-4 abrogates Wnt-3a-induced beta-catenin and Akt/PKB signalling and reverses a Wnt-3a- imposed inhibition of in vitro mammary differentiation. J Mol Signal May 2; 3:10. doi: 10.1186/1750-2187-3-10 PMID: 18452624
15. Jones SE, Jomary C, Grist J, Stewart HJ, Neal MJ. Altered expression of secreted frizzled-related protein-2 in retinitis pigmentosa retinas. Invest Ophthalmol Vis Sci. 2000 May 41(6):1297-301. PMID: 10798643
16. Horvath LG, Henshall SM, Kench JG, Saunders DN, Lee CS, Golovsky D, et al. Membranous Expression of Secreted Frizzled-Related Protein 4 Predicts for Good Prognosis in Localized Prostate Cancer and Inhibits PC3 Cellular Proliferation in Vitro. Clin Cancer Res 2004 Jan 15; 10(2):615-25. PMID: 14760084
17. Takagi H, Sasaki S, Suzuki H, Toyota M, Maruyama R, Nojima M, et al. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol 2008 Jul 43(5):378-89. doi: 10.1007/s00535-008-2170-0 PMID: 18592156
18. Pannone G, Bufo P, Santoro A, Franco R, Aquino G, Longo F, et al. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep 2010 Oct 24(4):1035-41. PMID: 20811686
19. Schiefer L, Visweswaran M, Perumal V, Arfuso F, Groth D, Newsholme P, et al. Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme. Cancer Gene Ther. 2014 Jul 21(7):297-303. doi: 10.1038/cgt.2014.30 PMID: 24948145
20. Warrier S, Kumar SB, Kumar PA, Michael M, Dharmarajan AM. Wnt Antagonist, Secreted Frizzled-Related Protein 4 (sFRP4), Increases Chemotherapeutic Response of Glioma Stem-Like Cells. Oncol Res 2014 Jan 21(2):93-102.
21. Warrier S, Bhuvanalakshmi G, Arfuso F, Rajan G, Millward M, Dharmarajan AM. Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition. Cancer Gene Ther 2014 Sep 21(9):381-8. doi: 10.1038/cgt.2014.42 PMID: 25104726
22. Jechlinger M, Podsypanina K, Varmus H. Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction. Genes Dev 2009 Jul 15; 23(14):1677-88. doi: 10.1101/gad.1801809 PMID: 19605689
23. Thiery JP and Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006 Feb 7(2):131-42. PMID: 16493418
24. Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 2005 Feb 1; 11(3):1154-9. PMID: 15709183
25. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006 Dec 7; 444(7120):756-60. PMID: 17051156
26. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, et al. A distinct "side population"of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 2004 Sep 28; 101(39):14228-33. PMID: 15381773
27. Feng Han Q, Zhao W, Bentel J, Shearwood AM, Zeps N, Joseph D, et al. Expression of Secreted Frizzled-Related Protein 4 (sFRP-4) and Beta-Catenin in Colorectal Carcinoma. Cancer Lett 2006 Jan 8; 231(1):129-37. PMID: 16356838
28. Hewitt DP, Mark PJ, Dharmarajan AM, Waddell BJ. Placental expression of secreted frizzled related protein-4 in rat and the impact of glucocorticoid-induced fetal and placental growth restriction. Biol Reprod 2006 Jul; 75(1):75-81. PMID: 16540541
29. Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, et al. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis 2013 Oct 24; 4:e875. doi: 10.1038/cddis.2013.407 PMID: 24157869
30. Visvader JE and Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008 Oct 8(10):755-68. doi: 10.1038/nrc2499 PMID: 18784658
31. Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM, et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 2011 Jan 27; 6(1):e16466 doi: 10.1371/journal.pone.0016466 PMID: 21304586
32. Lin YC, Lee YC, Li LH, Cheng CJ, Yang RB. Tumor suppressor SCUBE2 inhibits breast- cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. J Cell Sci 2014 Jan 1; 127(Pt 1):85-100.
33. Lu Y, Lu J, Li X, Zhu H, Fan X, Zhu S, et al. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. BMC Cancer 2014 Feb 12; 14:85. doi: 10.1186/1471-2407-14-85 PMID: 24521357
34. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 005 Jul 233(3):706-20. PMID: 15937929
35. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009 Nov 25; 139(5):871-90. doi: 10.1016/j.cell.2009.11.007 PMID: 19945376
36. Muley A, Majumder S, Kolluru GK, Parkinson S, Viola H, Hool L, et al. Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol 2010 Mar 176(3):1505-16. doi: 10.2353/ajpath.2010.090465 PMID: 20056841
37. Courtwright A, Siamakpour-Reihani S, Arbiser JL, Banet N, Hilliard E, Fried L, et al. Secreted frizzle-related protein 2 stimulates angiogenesisvia a calcineurin/NFAT signaling pathway. Cancer Res. 2009 Jun 1; 69(11):4621-8. doi: 10.1158/0008-5472.CAN-08-3402 PMID: 19458075
38. Kohn AD and Moon RT. Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 2005 Sep-Oct 38(3-4):439-46. PMID: 16219349
39. Maye P, Zheng J, Li L, Wu D. Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway. J Biol Chem 2004 Jun 4; 279(23):24659-65. PMID: 15067007
40. Simon SM and Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci U S A 1994 Apr 26; 91(9):3497-504. PMID: 7909602
41. Fletcher JI, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 2010 Feb 10(2):147-56. doi: 10.1038/nrc2789 PMID: 20075923
42. Saxena M, Stephens MA, Pathak H, Rangarajan A. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters Cell Death Dis 2011 Jul 7; 2:e179. doi: 10.1038/cddis.2011.61 PMID: 21734725
43. Bhuvanalakshmi G, Arfuso F, Dharmarajan A, Warrier S. Multifunctional properties of chicken embryonic prenatal mesenchymal stem cells- pluripotency, plasticity, and tumor suppression. Stem Cell Rev 2014 Dec 10(6):856-70. doi: 10.1007/s12015-014-9530-3 PMID: 24923881
44. Plasencia C, Dayam R, Wang Q, Pinski J, Burke TR Jr, Quinn DI, et al. Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and-independent cancer cell lines. Mol Cancer Ther 2005 Jul 4(7):1105-13. PMID: 16020668
45. Fulda S and Debatin KM. Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 2004 Sep 2; 23(40):6702-11. PMID: 15273734
46. Chen MP, Cabantchik ZI, Chan S, Chan GC, Cheung YF. Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade. PLoS One 2014 Nov 12; 9(11):e112915. doi: 10.1371/journal.pone.0112915 PMID: 25390893
47. Viola HM, Arthur PG, Hool LC.Transient exposure to hydrogen peroxide causes an increase in mitochondria-derived superoxide as a result of sustained alteration in L-type Ca2 channel function in the absence of apoptosis in ventricular myocytes. Circ Res 2007 Apr 13; 100(7):1036-44. PMID: 17347474
48. Liang CC, Park AY, Guan JL.In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007 2(2):329-33. PMID: 17406593
49. Annabi B, Rojas-Sutterlin S, Laflamme C, Lachambre MP, Rolland Y, Sartelet H, et al. Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype. Mol Cancer Res 2008 Jun 6(6):907-16. doi: 10.1158/1541-7786.MCR-07-2184 PMID: 18567795